Condensed Consolidated Statements of Stockholders' (Deficit)/Equity - USD ($)
|
Common Stock [Member] |
Treasury Stock [Member] |
Paid-in Capital [Member] |
Accumulated Deficit [Member] |
Total |
| Retroactive application of recapitalization at Dec. 31, 2022 |
$ 8,800
|
$ 0
|
$ 0
|
$ (8,581,300)
|
$ (8,572,500)
|
| Retroactive application of recapitalization (in shares) at Dec. 31, 2022 |
87,500,000
|
|
|
|
|
| Retroactive application of recapitalization (in shares) at Dec. 31, 2022 |
|
0
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
| Net Loss |
$ 0
|
$ 0
|
0
|
(210,300)
|
(210,300)
|
| Ending balance at Mar. 31, 2023 |
$ 8,800
|
$ 0
|
0
|
(8,791,600)
|
(8,782,800)
|
| Ending balance (in shares) at Mar. 31, 2023 |
87,500,000
|
|
|
|
|
| Ending balance (in shares) at Mar. 31, 2023 |
|
0
|
|
|
|
| Retroactive application of recapitalization at Dec. 31, 2022 |
$ 8,800
|
$ 0
|
0
|
(8,581,300)
|
(8,572,500)
|
| Retroactive application of recapitalization (in shares) at Dec. 31, 2022 |
87,500,000
|
|
|
|
|
| Retroactive application of recapitalization (in shares) at Dec. 31, 2022 |
|
0
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
| Net Loss |
|
|
|
|
(49,011,500)
|
| Conversion of convertible notes in common stock upon reverse capitalization |
|
|
|
|
0
|
| Ending balance at Sep. 30, 2023 |
$ 8,800
|
$ 0
|
0
|
(57,592,800)
|
(57,584,000)
|
| Ending balance (in shares) at Sep. 30, 2023 |
87,500,000
|
|
|
|
|
| Ending balance (in shares) at Sep. 30, 2023 |
|
0
|
|
|
|
| Retroactive application of recapitalization at Mar. 31, 2023 |
$ 8,800
|
$ 0
|
0
|
(8,791,600)
|
(8,782,800)
|
| Retroactive application of recapitalization (in shares) at Mar. 31, 2023 |
87,500,000
|
|
|
|
|
| Retroactive application of recapitalization (in shares) at Mar. 31, 2023 |
|
0
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
| Net Loss |
$ 0
|
$ 0
|
0
|
(22,768,100)
|
(22,768,100)
|
| Ending balance at Jun. 30, 2023 |
$ 8,800
|
$ 0
|
0
|
(31,559,700)
|
(31,550,900)
|
| Ending balance (in shares) at Jun. 30, 2023 |
87,500,000
|
|
|
|
|
| Ending balance (in shares) at Jun. 30, 2023 |
|
0
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
| Net Loss |
|
|
|
(26,033,100)
|
(26,033,100)
|
| Ending balance at Sep. 30, 2023 |
$ 8,800
|
$ 0
|
0
|
(57,592,800)
|
(57,584,000)
|
| Ending balance (in shares) at Sep. 30, 2023 |
87,500,000
|
|
|
|
|
| Ending balance (in shares) at Sep. 30, 2023 |
|
0
|
|
|
|
| Retroactive application of recapitalization at Dec. 31, 2023 |
$ 8,800
|
$ 0
|
0
|
(66,770,700)
|
(66,761,900)
|
| Retroactive application of recapitalization (in shares) at Dec. 31, 2023 |
87,500,000
|
|
|
|
|
| Retroactive application of recapitalization (in shares) at Dec. 31, 2023 |
|
0
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
| Net Loss |
$ 0
|
$ 0
|
0
|
(327,599,700)
|
(327,599,700)
|
| Fair value of TMTG earnout shares |
|
|
2,477,550,200
|
(2,477,550,200)
|
0
|
| Conversion of convertible notes in common stock upon reverse capitalization |
$ 600
|
$ 0
|
300,425,400
|
0
|
300,426,000
|
| Conversion of convertible notes in common stock upon reverse capitalization (in shares) |
6,014,534
|
0
|
|
|
|
| Stock Based Compensation |
$ 200
|
$ 0
|
84,587,800
|
0
|
84,588,000
|
| Stock Based Compensation (in shares) |
1,840,000
|
0
|
|
|
|
| Issuance of common stock upon reverse capitalization |
$ 4,100
|
$ 0
|
219,617,500
|
0
|
219,621,600
|
| Issuance of common stock upon reverse capitalization (in shares) |
41,346,049
|
0
|
|
|
|
| Ending balance at Mar. 31, 2024 |
$ 13,700
|
$ 0
|
3,082,180,900
|
(2,871,920,600)
|
210,274,000
|
| Ending balance (in shares) at Mar. 31, 2024 |
136,700,583
|
|
|
|
|
| Ending balance (in shares) at Mar. 31, 2024 |
|
0
|
|
|
|
| Retroactive application of recapitalization at Dec. 31, 2023 |
$ 8,800
|
$ 0
|
0
|
(66,770,700)
|
(66,761,900)
|
| Retroactive application of recapitalization (in shares) at Dec. 31, 2023 |
87,500,000
|
|
|
|
|
| Retroactive application of recapitalization (in shares) at Dec. 31, 2023 |
|
0
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
| Net Loss |
|
|
|
|
(363,216,100)
|
| Conversion of convertible notes in common stock upon reverse capitalization |
|
|
|
|
350,426,000
|
| Common stock issued for cash |
$ 87,500,000
|
|
|
|
$ 87,500,000
|
| Common stock issued for cash (in shares) |
100,000,000
|
|
|
|
100,000,000
|
| Ending balance at Sep. 30, 2024 |
$ 21,500
|
$ (2,908,700)
|
3,726,957,300
|
(2,907,537,000)
|
$ 816,533,100
|
| Ending balance (in shares) at Sep. 30, 2024 |
214,517,760
|
|
|
|
|
| Ending balance (in shares) at Sep. 30, 2024 |
|
(128,138)
|
|
|
|
| Retroactive application of recapitalization at Mar. 31, 2024 |
$ 13,700
|
$ 0
|
3,082,180,900
|
(2,871,920,600)
|
210,274,000
|
| Retroactive application of recapitalization (in shares) at Mar. 31, 2024 |
136,700,583
|
|
|
|
|
| Retroactive application of recapitalization (in shares) at Mar. 31, 2024 |
|
0
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
| Net Loss |
|
|
|
(16,368,000)
|
(16,368,000)
|
| Exercise of warrants |
$ 900
|
$ 0
|
97,761,400
|
0
|
97,762,300
|
| Exercise of warrants (in shares) |
8,526,792
|
0
|
|
|
|
| Issuance of earnout shares |
$ 4,000
|
$ 0
|
(4,000)
|
0
|
0
|
| Issuance of earnout shares (in shares) |
40,000,000
|
0
|
|
|
|
| Conversion of convertible notes in common stock upon reverse capitalization |
$ 600
|
$ 0
|
49,999,400
|
0
|
50,000,000
|
| Conversion of convertible notes in common stock upon reverse capitalization (in shares) |
6,250,000
|
0
|
|
|
|
| Ending balance at Jun. 30, 2024 |
$ 19,200
|
$ 0
|
3,229,937,700
|
(2,888,288,600)
|
341,668,300
|
| Ending balance (in shares) at Jun. 30, 2024 |
191,477,375
|
|
|
|
|
| Ending balance (in shares) at Jun. 30, 2024 |
|
0
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
| Net Loss |
$ 0
|
$ 0
|
0
|
(19,248,400)
|
(19,248,400)
|
| Exercise of warrants |
$ 200
|
$ 0
|
20,222,600
|
0
|
20,222,800
|
| Exercise of warrants (in shares) |
1,758,501
|
0
|
|
|
|
| Common stock issued for cash |
$ 1,700
|
$ 0
|
344,742,500
|
0
|
344,744,200
|
| Common stock issued for cash (in shares) |
17,655,365
|
0
|
|
|
|
| Acquisition of WCT, net of offering costs |
$ 300
|
$ 0
|
132,009,100
|
0
|
132,009,400
|
| Acquisition of WCT, net of offering costs (in shares) |
2,600,000
|
0
|
|
|
|
| Issuance of common stock for services |
$ 0
|
$ 0
|
45,500
|
0
|
45,500
|
| Issuance of common stock for services (in shares) |
2,002
|
0
|
|
|
|
| Treasury Stock |
|
$ (2,908,700)
|
0
|
0
|
(2,908,700)
|
| Treasury stock (in shares) |
|
(128,138)
|
|
|
|
| Common stock for ARC settlement |
$ 100
|
$ 0
|
(100)
|
0
|
0
|
| Common stock for ARC settlement (in shares) |
1,024,517
|
0
|
|
|
|
| Ending balance at Sep. 30, 2024 |
$ 21,500
|
$ (2,908,700)
|
$ 3,726,957,300
|
$ (2,907,537,000)
|
$ 816,533,100
|
| Ending balance (in shares) at Sep. 30, 2024 |
214,517,760
|
|
|
|
|
| Ending balance (in shares) at Sep. 30, 2024 |
|
(128,138)
|
|
|
|